CASE REPORT |
|
Year : 2016 | Volume
: 26
| Issue : 4 | Page : 280-283 |
Epstein-Barr virus-positive multiple myeloma following an ABO incompatible second renal transplantation
B Kirushnan1, B Subbarao1, P Prabhu2
1 Department of Nephrology, Apollo Hospitals, Chennai, Tamil Nadu, India 2 Department of Hematology, Apollo Hospitals, Chennai, Tamil Nadu, India
Correspondence Address:
B Kirushnan Flat No. 11, Shanti Enclave, No. 71, Venkatakrishna Road, R. A. Puram, Chennai - 600 028, Tamil Nadu India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0971-4065.168143
ABO incompatible kidney transplant recipients receive higher dose of immunosuppression. Previous data indicate that the incidence of malignancy is not higher in these patients. Compared to the general population, renal transplant recipients are at 4.4-fold higher risk of developing myeloma. We describe a case of posttransplant multiple myeloma in an ABO incompatible renal transplant recipient of a second graft.
[FULL TEXT] [PDF]*
|